NIH-funded research Career grant

Identifying biological markers for early aging in people with schizophrenia

Official title: Towards Developing Biomarkers for Premature Aging in Schizophrenia

Funded at Brigham and Women's Hospital · NIH-10898917 · Data updated 2026-11-12

This study is looking at how schizophrenia might make people age faster by checking for certain proteins in their bodies, and it's for anyone with schizophrenia who wants to understand more about their health and how it relates to aging.

More Aging research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 3, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$130,598
NIH project number5K99MH131850-02
Project IDNIH-10898917 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with early-stage schizophrenia who may be experiencing signs of premature aging.

Less likely to help

Patients with schizophrenia who are not in the early stages of the condition or those without any signs of premature aging may not benefit from this research.

What this research studies

This research investigates how schizophrenia may lead to premature aging by examining biological markers associated with this condition. The study aims to identify specific proteins that indicate aging in individuals with schizophrenia, which could help in diagnosing and monitoring their health. By analyzing data from both individuals with early schizophrenia and healthy controls, the research seeks to uncover the links between aging, cognitive function, and physical health in this population. The ultimate goal is to develop new diagnostic tools that can be used in clinical settings to better support patients.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for individuals with schizophrenia, enhancing their overall health and quality of life.

How similar studies have gone: Previous research has indicated a connection between schizophrenia and premature aging, but this specific approach to identifying biomarkers is relatively novel.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Seitz-Holland, Johanna — Brigham and Women's Hospital
  • Study coordinator: Seitz-Holland, Johanna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.